TrialWorld journal of surgical oncology2009

Taurolidine reduces the tumor stimulating cytokine interleukin-1beta in patients with resectable gastrointestinal cancer: a multicentre prospective randomized trial.

Chris Braumann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.